Evidence map›Paper›PMID 41395273›Full record

ReviewBiochemistry research international2025

Type 1 Diabetes Autoimmunity: To What Extent Vitamin D is Beneficial.

Haitham Al-Madhagi

Abstract readReview
In one paragraph

Review in Biochemistry research international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Haitham Al-MadhagiBiochemical Technology Program, Dhamar University, Dhamar, Yemen.ORCID https://orcid.org/0000-0002-3850-244X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autoimmune disorders, characterized by an overactive immune system attacking healthy tissues, are a significant global health concern. A common thread among these disorders is vitamin D deficiency. While the exact relationship between vitamin D and autoimmunity remains a hot research arena, plenty of reports have suggested a strong association between vitamin D and autoimmune conditions, including systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, and Type 1 diabetes, among others. Type 1 diabetes, in particular, has been extensively studied in relation to vitamin D. Evidence suggests that vitamin D deficiency may play a role in the development of this autoimmune disease. Beyond its well-known function in bone health, vitamin D acts as a key regulator of both innate and adaptive immune responses. This review sought to explore the complex interplay between vitamin D and the immune system, with a particular focus on its potential role in autoimmunity, especially Type 1 diabetes. Moreover, the coupled therapy and clinical trials that have investigated the use of vitamin D as a therapeutic intervention for autoimmune disorders were also examined, highlighting both successes and limitations.

Indexed as

autoimmune disordersautoimmunityclinical trialsType 1 diabetesvitamin D

Identifiers

PMID41395273
PMCPMC12698266

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.